Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: DPP-4 inhibitor + SGLT2 inhibitor + biguanide (Triple OAD)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Type-2 DM uncontrolled on dual OAD
- Patients with significant hyperglycaemia
- Combined cardiovascular and renal risk reduction
Mechanism of Action
Linagliptin inhibits DPP-4, prolonging incretin activity to enhance glucose-dependent insulin secretion. Dapagliflozin inhibits renal SGLT2, increasing urinary glucose excretion. Metformin activates AMPK to reduce hepatic glucose output and improve peripheral insulin sensitivity. The triple combination covers three complementary glycaemic mechanisms.
Dosage & Administration
- Adults: 1 tablet once daily in the morning
- Swallow whole
- Take with food to minimise GI side effects
- Use under physician supervision
Side Effects
- GI upset (metformin)
- Genital mycotic infection
- Urinary tract infection
- Polyuria
- Nasopharyngitis
Contraindications
- Type-1 diabetes
- History of diabetic ketoacidosis
- eGFR < 30
- Severe hepatic impairment
- Active urogenital infection
- Pregnancy and breastfeeding
Storage
Store below 25°C.
PCD Pharma Franchise for Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet?
MRPs range from ₹2190 to ₹2190 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Linagliptin 5 mg + Dapagliflozin 10 mg + Metformin 500 mg (SR) Tablet?